<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>US FDA Quality Metrics Guidelines Update</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/us-fda-quality-metrics-guidelines-update</link><description>Author: Eric Kuebler 
Since the Continued Process Verification (CPV) guidance in 2011, the U.S. Food and Drug Administration (FDA) has been talking quality and verifying process state of control.
Now the FDA is getting around to defining what that lo</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>